These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31835579)

  • 41. Chitosan promotes cancer progression and stem cell properties in association with Wnt signaling in colon and hepatocellular carcinoma cells.
    Chang PH; Sekine K; Chao HM; Hsu SH; Chern E
    Sci Rep; 2017 Apr; 8():45751. PubMed ID: 28367998
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bile acid: a potential inducer of colon cancer stem cells.
    Farhana L; Nangia-Makker P; Arbit E; Shango K; Sarkar S; Mahmud H; Hadden T; Yu Y; Majumdar AP
    Stem Cell Res Ther; 2016 Dec; 7(1):181. PubMed ID: 27908290
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Evodiamine induces extrinsic and intrinsic apoptosis of ovarian cancer cells via the mitogen-activated protein kinase/phosphatidylinositol-3-kinase/protein kinase B signaling pathways].
    Wei L; Jin X; Cao Z; Li W
    J Tradit Chin Med; 2016 Jun; 36(3):353-9. PubMed ID: 27468551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells.
    Ponnurangam S; Dandawate PR; Dhar A; Tawfik OW; Parab RR; Mishra PD; Ranadive P; Sharma R; Mahajan G; Umar S; Weir SJ; Sugumar A; Jensen RA; Padhye SB; Balakrishnan A; Anant S; Subramaniam D
    Oncotarget; 2016 Jan; 7(3):3217-32. PubMed ID: 26673007
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sanguinarine inhibits pancreatic cancer stem cell characteristics by inducing oxidative stress and suppressing sonic hedgehog-Gli-Nanog pathway.
    Ma Y; Yu W; Shrivastava A; Alemi F; Lankachandra K; Srivastava RK; Shankar S
    Carcinogenesis; 2017 Oct; 38(10):1047-1056. PubMed ID: 28968696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NEAT1 contributes to the CSC-like traits of A549/CDDP cells via activating Wnt signaling pathway.
    Jiang P; Xu H; Xu C; Chen A; Chen L; Zhou M; Haq IU; Wu X; Mariyam Z; Feng Q
    Chem Biol Interact; 2018 Dec; 296():154-161. PubMed ID: 30291867
    [TBL] [Abstract][Full Text] [Related]  

  • 47. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
    Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 in triple-negative breast cancer cells.
    Koike Y; Ohta Y; Saitoh W; Yamashita T; Kanomata N; Moriya T; Kurebayashi J
    Breast Cancer; 2017 Sep; 24(5):683-693. PubMed ID: 28144905
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Berberine and Evodiamine Act Synergistically Against Human Breast Cancer MCF-7 Cells by Inducing Cell Cycle Arrest and Apoptosis.
    Du J; Sun Y; Lu YY; Lau E; Zhao M; Zhou QM; Su SB
    Anticancer Res; 2017 Nov; 37(11):6141-6151. PubMed ID: 29061795
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pien Tze Huang inhibits the proliferation, and induces the apoptosis and differentiation of colorectal cancer stem cells via suppression of the Notch1 pathway.
    Qi F; Wei L; Shen A; Chen Y; Lin J; Chu J; Cai Q; Pan J; Peng J
    Oncol Rep; 2016 Jan; 35(1):511-7. PubMed ID: 26530025
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting Wnt signaling: can we safely eradicate cancer stem cells?
    Takahashi-Yanaga F; Kahn M
    Clin Cancer Res; 2010 Jun; 16(12):3153-62. PubMed ID: 20530697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Controversies in cancer stem cells: targeting embryonic signaling pathways.
    Takebe N; Ivy SP
    Clin Cancer Res; 2010 Jun; 16(12):3106-12. PubMed ID: 20530695
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway.
    Yang J; Liao D; Chen C; Liu Y; Chuang TH; Xiang R; Markowitz D; Reisfeld RA; Luo Y
    Stem Cells; 2013 Feb; 31(2):248-58. PubMed ID: 23169551
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction of phosphatase shatterproof 2 by evodiamine suppresses the proliferation and invasion of human cholangiocarcinoma.
    Zhu B; Zhao L; Liu Y; Jin Y; Feng J; Zhao F; Sun J; Geng R; Wei Y
    Int J Biochem Cell Biol; 2019 Mar; 108():98-110. PubMed ID: 30682488
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of evodiamine on the proliferation and apoptosis of A549 human lung cancer cells.
    Lin L; Ren L; Wen L; Wang Y; Qi J
    Mol Med Rep; 2016 Sep; 14(3):2832-8. PubMed ID: 27485202
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Notch inhibition suppresses nasopharyngeal carcinoma by depleting cancer stem-like side population cells.
    Yu S; Zhang R; Liu F; Wang H; Wu J; Wang Y
    Oncol Rep; 2012 Aug; 28(2):561-6. PubMed ID: 22641197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic Potential, Challenges and Future Perspective of Cancer Stem Cells in Translational Oncology: A Critical Review.
    Shukla G; Khera HK; Srivastava AK; Khare P; Patidar R; Saxena R
    Curr Stem Cell Res Ther; 2017; 12(3):207-224. PubMed ID: 27804866
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Berberine counteracts enhanced IL-8 expression of AGS cells induced by evodiamine.
    Shi HL; Wu XJ; Liu Y; Xie JQ
    Life Sci; 2013 Nov; 93(22):830-9. PubMed ID: 24063987
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
    Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
    J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
    Yan Y; Liu F; Han L; Zhao L; Chen J; Olopade OI; He M; Wei M
    J Exp Clin Cancer Res; 2018 Oct; 37(1):256. PubMed ID: 30340507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.